Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M(1) and M(4) receptors. Chatterjee S, Soria M, Norville ZC, Thompson KR, et al. Neuropsychopharmacology 2025 Oct 4. doi: 10.1038/s41386-025-02256.

Read + Share

Amedeo Smart

Independent Medical Education

Chatterjee S, Soria M, Norville ZC, Thompson KR, et al. Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M(1) and M(4) receptors. Neuropsychopharmacology 2025 Oct 4. doi: 10.1038/s41386-025-02256.
PMID: 41046244